DARE Stock Analysis: Buy, Sell, or Hold?
DARE - Dare Bioscience, Inc. Common Stock
$2.86
0.02 (0.70%)
▲
5d:
-1.72%
30d:
+59.78%
90d:
+68.24%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When DARE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DARE trades at premium valuation expecting 11.4% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: DARE trades at premium valuation expecting 11.4% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.87
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DARE is currently trading at $2.86, which is considered extended relative to its 30-day fair value range of $1.91 to $2.85. From a valuation perspective, the stock is trading at a premium (Forward PE: 4.8) compared to its historical average (3.5). At these levels, the market is pricing in 11.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DARE is in a uptrend. Immediate support is located at $2.28, while resistance sits at $3.78.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.67 (+240.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DARE is in a uptrend. Immediate support is located at $2.28, while resistance sits at $3.78.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.67 (+240.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.91 -
$2.85
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
45.2%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading 240.4% below Wall St target ($9.67)
- NEUTRAL: Trading at premium valuation - market expects 11.4% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$1.91 -
$2.85
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.28
Resistance Level
$3.78
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
4.85
Wall Street Target
$9.67
(+240.4%)
Revenue Growth (YoY)
-94.6%
Valuation Premium vs History
+11.4% premium
PE vs Historical
4.9 vs 3.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.4%
(market-implied from PE analysis)
1-Year Target
$3.16
(+11%)
2-Year Target
$3.52
(+24%)
3-Year Target
$3.93
(+38%)
3-Yr Target (if PE normalizes)
(PE: 5→4)
PE COMPRESSION
$2.83
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 14, 2026 4:34 PM ET
Data refreshes hourly during market hours. Next update: 5:34 PM
Data refreshes hourly during market hours. Next update: 5:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DARE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 63 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$104 | 60 BUY |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 54 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$181 | 59 HOLD |
|
VYGR
Voyager Therapeutics Inc |
STRONG BUY
12 analysts |
$15 | 58 HOLD |
